GB9204565D0 - Pharmaceuticals - Google Patents

Pharmaceuticals

Info

Publication number
GB9204565D0
GB9204565D0 GB929204565A GB9204565A GB9204565D0 GB 9204565 D0 GB9204565 D0 GB 9204565D0 GB 929204565 A GB929204565 A GB 929204565A GB 9204565 A GB9204565 A GB 9204565A GB 9204565 D0 GB9204565 D0 GB 9204565D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceuticals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929204565A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB929204565A priority Critical patent/GB9204565D0/en
Publication of GB9204565D0 publication Critical patent/GB9204565D0/en
Priority to CA002131381A priority patent/CA2131381A1/en
Priority to NZ249217A priority patent/NZ249217A/en
Priority to PCT/GB1993/000395 priority patent/WO1993018027A1/en
Priority to AU35718/93A priority patent/AU666357B2/en
Priority to EP93904259A priority patent/EP0629198A1/en
Priority to JP5515422A priority patent/JPH07504428A/ja
Priority to ZA931430A priority patent/ZA931430B/xx
Priority to MX9301157A priority patent/MX9301157A/es
Priority to TW082102087A priority patent/TW279857B/zh
Priority to KR1019940703105A priority patent/KR950700285A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
GB929204565A 1992-03-03 1992-03-03 Pharmaceuticals Pending GB9204565D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GB929204565A GB9204565D0 (en) 1992-03-03 1992-03-03 Pharmaceuticals
JP5515422A JPH07504428A (ja) 1992-03-03 1993-02-25 医薬として有用な窒素含有複素環化合物
AU35718/93A AU666357B2 (en) 1992-03-03 1993-02-25 Indole or benzimidazole derivatives
NZ249217A NZ249217A (en) 1992-03-03 1993-02-25 Indole and 2-oxo-benzimidazole derivatives and medicaments
PCT/GB1993/000395 WO1993018027A1 (en) 1992-03-03 1993-02-25 Nitrogen containing heterocyclic compounds useful as pharmaceuticals
CA002131381A CA2131381A1 (en) 1992-03-03 1993-02-25 Nitrogen containing heterocyclic compounds useful as pharmaceuticals
EP93904259A EP0629198A1 (en) 1992-03-03 1993-02-25 Nitrogen containing heterocyclic compounds useful as pharmaceuticals
ZA931430A ZA931430B (en) 1992-03-03 1993-03-01 Pharmaceuticals
MX9301157A MX9301157A (es) 1992-03-03 1993-03-02 Derivados de bencimidazolona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
TW082102087A TW279857B (ja) 1992-03-03 1993-03-20
KR1019940703105A KR950700285A (ko) 1992-03-03 1994-09-02 약제로서 유용한 질소 함유 헤테로시클릭 화합물(Nitrogen containing heterocyclk compounds useful as pharmaceuticals)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929204565A GB9204565D0 (en) 1992-03-03 1992-03-03 Pharmaceuticals

Publications (1)

Publication Number Publication Date
GB9204565D0 true GB9204565D0 (en) 1992-04-15

Family

ID=10711400

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929204565A Pending GB9204565D0 (en) 1992-03-03 1992-03-03 Pharmaceuticals

Country Status (11)

Country Link
EP (1) EP0629198A1 (ja)
JP (1) JPH07504428A (ja)
KR (1) KR950700285A (ja)
AU (1) AU666357B2 (ja)
CA (1) CA2131381A1 (ja)
GB (1) GB9204565D0 (ja)
MX (1) MX9301157A (ja)
NZ (1) NZ249217A (ja)
TW (1) TW279857B (ja)
WO (1) WO1993018027A1 (ja)
ZA (1) ZA931430B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998409A (en) * 1992-03-12 1999-12-07 Smithkline Beecham Plc Condensed indole derivatives as 5HT4 -receptor antagonists
US5852014A (en) * 1992-03-12 1998-12-22 Smithkline Beecham P.L.C. Condensed indole derivatives as 5HT4 -receptor antagonists
JPH08502283A (ja) * 1992-10-16 1996-03-12 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５−ｈｔ▲下４▼レセプターアンタゴニスト用の縮合環系ｎ−アルキルピペリジニル−４−メチルカルボン酸エステル／アミド
GB9310582D0 (en) * 1993-05-22 1993-07-07 Smithkline Beecham Plc Pharmaceuticals
IT1275903B1 (it) * 1995-03-14 1997-10-24 Boehringer Ingelheim Italia Esteri e ammidi della 1,4-piperidina disostituita
KR20010043032A (ko) * 1998-04-28 2001-05-25 도모따께 다께시 1-[(1-치환-4-피페리디닐)메틸]-4-피페리딘 유도체, 그의제조방법, 그것을 함유하는의약조성물 및 이 화합물의중간체
ES2377484T3 (es) 2003-09-03 2012-03-28 Pfizer, Inc. Compuestos de bencimidazolona que tiene actividad agonista del receptor 5-HT
US7737163B2 (en) 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
AP2418A (en) * 2004-06-15 2012-06-04 Pfizer Benzimidazolone carboxylic acid derivatives.
GEP20094638B (en) 2004-06-15 2009-03-10 Pfizer Benzimidazolone carboxylic acid derivatives
JP2008509088A (ja) * 2004-09-02 2008-03-27 ファイザー株式会社 ベンズイミダゾロンカルボン酸誘導体
EA012615B1 (ru) 2005-02-22 2009-10-30 Пфайзер Инк. Производные оксииндола в качестве агонистов 5-htрецептора
ATE493391T1 (de) 2005-03-15 2011-01-15 Pfizer Benzimidazolonderivate als cb2-rezeptor-liganden
AU2011270701B2 (en) * 2010-06-24 2015-05-14 Alkermes Pharma Ireland Limited Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3687980T2 (de) * 1986-01-07 1993-06-17 Beecham Group Plc Indolderivate mit einer azabicyclischen seitenkette, verfahren zu ihrer herstellung, zwischenprodukte und pharmazeutische zusammensetzungen.
IT1231413B (it) * 1987-09-23 1991-12-04 Angeli Inst Spa Derivati dell'acido benzimidazolin-2-osso-1-carbossilico utili come antagonisti dei recettori 5-ht

Also Published As

Publication number Publication date
JPH07504428A (ja) 1995-05-18
NZ249217A (en) 1996-06-25
AU666357B2 (en) 1996-02-08
AU3571893A (en) 1993-10-05
MX9301157A (es) 1994-07-29
EP0629198A1 (en) 1994-12-21
CA2131381A1 (en) 1993-09-16
WO1993018027A1 (en) 1993-09-16
TW279857B (ja) 1996-07-01
ZA931430B (en) 1993-10-22
KR950700285A (ko) 1995-01-16

Similar Documents

Publication Publication Date Title
AP9300494A0 (en) Pharmaceuticals
GB9221468D0 (en) Pharmaceuticals
ZA931430B (en) Pharmaceuticals
GB9219163D0 (en) Pharmaceuticals
GB9205917D0 (en) Pharmaceuticals
GB9214184D0 (en) Pharmaceuticals
GB9201961D0 (en) Pharmaceuticals
GB9220585D0 (en) Pharmaceuticals
GB9208321D0 (en) Pharmaceuticals
GB9211926D0 (en) Pharmaceuticals
GB9201946D0 (en) Pharmaceuticals
GB9205427D0 (en) Pharmaceuticals
GB9205428D0 (en) Pharmaceuticals
GB9205363D0 (en) Pharmaceuticals
GB9205918D0 (en) Pharmaceuticals
GB9206075D0 (en) Pharmaceuticals
GB9207414D0 (en) Pharmaceuticals
GB9221774D0 (en) Pharmaceuticals
GB9203977D0 (en) Pharmaceuticals
GB9208434D0 (en) Pharmaceuticals
GB9211072D0 (en) Pharmaceuticals
GB9211082D0 (en) Pharmaceuticals
GB9211925D0 (en) Pharmaceuticals
GB9221769D0 (en) Pharmaceuticals
GB9211978D0 (en) Pharmaceuticals